EP 1934249 A1 20080625 - ANTAGONISTS AGAINST INTERACTION OF PF4 AND RANTES
Title (en)
ANTAGONISTS AGAINST INTERACTION OF PF4 AND RANTES
Title (de)
ANTAGONISTEN GEGEN DIE INTERAKTION VON PF4 UND RANTES
Title (fr)
ANTAGONISTES UTILISES CONTRE L'INTERACTION DE PF4 ET DE RANTES
Publication
Application
Priority
- EP 2006009790 W 20061011
- DE 102005049637 A 20051014
Abstract (en)
[origin: WO2007042263A1] The invention relates to polypeptides of amino acid sequence SEQ ID NO: 1 according to formula (1), the use thereof for producing a medicament, and medicaments for the treatment of diseases related to monocyte recruitment.
IPC 8 full level
C07K 14/52 (2006.01)
CPC (source: EP KR US)
A61K 49/0008 (2013.01 - EP US); A61P 1/00 (2017.12 - EP); A61P 1/04 (2017.12 - EP); A61P 7/00 (2017.12 - EP); A61P 7/02 (2017.12 - EP); A61P 9/00 (2017.12 - EP); A61P 9/08 (2017.12 - EP); A61P 9/10 (2017.12 - EP); A61P 9/12 (2017.12 - EP); A61P 11/00 (2017.12 - EP); A61P 11/06 (2017.12 - EP); A61P 17/00 (2017.12 - EP); A61P 17/06 (2017.12 - EP); A61P 19/02 (2017.12 - EP); A61P 21/00 (2017.12 - EP); A61P 25/00 (2017.12 - EP); A61P 29/00 (2017.12 - EP); A61P 37/02 (2017.12 - EP); A61P 37/06 (2017.12 - EP); A61P 37/08 (2017.12 - EP); A61P 43/00 (2017.12 - EP); C07K 14/00 (2013.01 - KR); C07K 14/52 (2013.01 - KR); C07K 14/523 (2013.01 - EP US); A61K 38/00 (2013.01 - EP US)
Citation (search report)
See references of WO 2007042263A1
Citation (examination)
- DE 10014516 A1 20010927 - WEBER CHRISTIAN [DE]
- KOENEN RORY R ET AL: "Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice", NATURE MEDICINE, NATURE PUBLISHING GROUP, NEW YORK, NY, US, vol. 15, no. 1, 1 January 2009 (2009-01-01), pages 97 - 103, XP009144429, ISSN: 1078-8956, DOI: 10.1038/NM.1898
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
Designated extension state (EPC)
AL BA HR MK RS
DOCDB simple family (publication)
WO 2007042263 A1 20070419; AU 2006301494 A1 20070419; AU 2006301494 B2 20110106; BR PI0617384 A2 20110726; CA 2648649 A1 20070419; CN 101356190 A 20090128; CN 101356190 B 20121114; CN 102911260 A 20130206; DE 102005049637 A1 20070426; EA 013508 B1 20100630; EA 200801077 A1 20081230; EP 1934249 A1 20080625; EP 2363412 A1 20110907; EP 2363412 B1 20150610; ES 2546094 T3 20150918; HK 1127069 A1 20090918; IL 190820 A0 20081103; JP 2009511029 A 20090319; JP 5385611 B2 20140108; KR 101477767 B1 20150102; KR 20080080093 A 20080902; MX 2008004866 A 20081020; NO 20082127 L 20080708; US 2008287652 A1 20081120; US 2012077733 A1 20120329; US 8110552 B2 20120207; US 8501680 B2 20130806; ZA 200804081 B 20091125
DOCDB simple family (application)
EP 2006009790 W 20061011; AU 2006301494 A 20061011; BR PI0617384 A 20061011; CA 2648649 A 20061011; CN 200680044626 A 20061011; CN 201210366046 A 20061011; DE 102005049637 A 20051014; EA 200801077 A 20061011; EP 06806162 A 20061011; EP 10181077 A 20061011; ES 10181077 T 20061011; HK 09106227 A 20090713; IL 19082008 A 20080413; JP 2008534921 A 20061011; KR 20087011438 A 20061011; MX 2008004866 A 20061011; NO 20082127 A 20080506; US 201113315088 A 20111208; US 9001006 A 20061011; ZA 200804081 A 20061011